Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Clearpoint Neuro Inc (CLPT)

Clearpoint Neuro Inc (CLPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 355,912
  • Shares Outstanding, K 27,420
  • Annual Sales, $ 23,960 K
  • Annual Income, $ -22,090 K
  • 60-Month Beta 1.07
  • Price/Sales 15.18
  • Price/Cash Flow N/A
  • Price/Book 11.25
Trade CLPT with:

Options Overview Details

View History
  • Implied Volatility 63.49% ( -6.86%)
  • Historical Volatility 116.39%
  • IV Percentile 30%
  • IV Rank 39.30%
  • IV High 152.88% on 03/15/24
  • IV Low 5.61% on 09/19/23
  • Put/Call Vol Ratio 0.35
  • Today's Volume 23
  • Volume Avg (30-Day) 155
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 3,163
  • Open Int (30-Day) 2,482

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.14
  • Low Estimate -0.19
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +15.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.25 +107.68%
on 08/05/24
13.47 -3.64%
on 08/30/24
+5.77 (+80.03%)
since 07/30/24
3-Month
5.11 +154.01%
on 07/02/24
13.47 -3.64%
on 08/30/24
+7.43 (+133.87%)
since 05/30/24
52-Week
4.05 +220.49%
on 11/10/23
13.47 -3.64%
on 08/30/24
+7.30 (+128.52%)
since 08/29/23

Most Recent Stories

More News
ClearPoint Neuro, Inc. (CLPT) Q2 2022 Earnings Call Transcript

CLPT earnings call for the period ending June 30, 2022.

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Reports Second Quarter 2022 Results

Record Quarterly Revenue Achieved; Company Reaffirms 2022 Revenue Forecast...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency

First Gene Therapy Approved for Direct Infusion into the Brain will be Administered with ClearPoint’s SmartFlow® Neuro Cannula...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy

SOLANA BEACH, Calif., June 29, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency

First Gene Therapy Directly Infused into the Brain to be Administered with ClearPoint’s SmartFlow® Cannula...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro to Present Investigational Research and Exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC

SOLANA BEACH, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Call Transcript

CLPT earnings call for the period ending March 31, 2022.

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Reports First Quarter 2022 Results

SOLANA BEACH, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1

Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room...

CLPT : 12.98 (-1.52%)
ClearPoint Neuro to Announce First Quarter 2022 Results May 11, 2022

SOLANA BEACH, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform...

CLPT : 12.98 (-1.52%)

Business Summary

ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.

See More

Key Turning Points

3rd Resistance Point 14.10
2nd Resistance Point 13.79
1st Resistance Point 13.38
Last Price 12.98
1st Support Level 12.66
2nd Support Level 12.35
3rd Support Level 11.94

See More

52-Week High 13.47
Last Price 12.98
Fibonacci 61.8% 9.87
Fibonacci 50% 8.76
Fibonacci 38.2% 7.65
52-Week Low 4.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar